Interpace Biosciences Inc. – Filings and Transcripts

OTC: IDXG
Share price (4/17/26): $2.13
Market cap (4/17/26): $59.1 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024 – amended

Prospectuses and Registrations Filter

Exempt offering of securities

Registration withdrawal request

Prospectus supplement with pricing info

Additional exhibits for registration

Initial registration of new securities – amended

Ownership Filter

1315 Capital II, L.P.

Ampersand 2018 Limited Partnership

McCarthy Christopher

Singer Douglas Mark

Singer Douglas Mark

News Filter

Announces Fourth Quarter and Full Year 2025 Financial and Business Results

Announces Preliminary 2025 Revenue, 2026 Revenue Guidance and Simplification of Capital Structure

Announces Early Repayment of Debt to BroadOak Capital Partners

Announces Third Quarter 2025 Financial and Business Results

Announces Second Quarter 2025 Financial and Business Results

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Letter from the SEC

Correspondence with the SEC